DOI: 10.1055/s-00000059

Pneumologie

References

Abdulqawi R, Dockry R, Holt K. et al.
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.

The Lancet 2015;
385: 1198-1205

Abdulqawi R, Dockry R, Holt K. et al.
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.

The Lancet 2015;
385: 1198-1205

Download Bibliographical Data

Search in:
Access: